Clinical Trial Update: Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of PCSK9 inhibitors on coronary atherosclerotic plaques in patients with coronary artery disease, assessed by optic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Praluent (alirocumab)
• Repatha (Evolocumab)

Snippet

Sponsor: First Affiliated Hospital of Xinjiang Medical University | Conditions: Coronary Artery Disease, Optical Coherence Tomography | Phase 4 | Status: RECRUITING